<DOC>
	<DOCNO>NCT00544258</DOCNO>
	<brief_summary>The purpose study determine extent systemic absorption PEP005 apply topically treatment actinic keratoses .</brief_summary>
	<brief_title>Pharmacokinetic Study Evaluate Extent Systemic Absorption PEP005</brief_title>
	<detailed_description>Actinic keratoses ( AK ) common skin condition characterize rough , scaly patch sores top layer skin leave untreated progress skin cancer . Current treatment cause scar hypopigmentation , inconvenient , require long treatment duration . Non-invasive alternative therapy treatment AK lesion thus research .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>1 . Male patient least 18 year age . 2 . A contiguous 100 cm2 treatment area contain least 5 AK lesion , either right left extensor ( dorsal aspect ) forearm . 3 . Written inform consent obtain . 4 . Agreement patient allow photograph select AK treatment area take used part study package .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Pharmacokinetic study</keyword>
	<keyword>Actinic Keratosis</keyword>
	<keyword>Topical</keyword>
	<keyword>Dermatology</keyword>
</DOC>